Hawley Advocates for Removal of Predominant U.S. Abortion Pill from Market

Since the landmark decision overturning Roe v. Wade, many pro-life supporters have been focused on a significant question: With abortion pills now responsible for the majority of terminations in the United States, when will the federal government address the issue of these medications?

Senator Josh Hawley from Missouri believes that time is now.

This week, Hawley introduced a bill aiming to withdraw the Food and Drug Administration’s approval of mifepristone, a drug that has become central to the abortion debate in the wake of Roe‘s reversal. This proposed legislation seeks to bring Congress into direct conflict with the FDA, the agency that sanctioned the drug over 20 years ago.

Currently, medication-induced abortions make up approximately 63% of all abortion procedures in the country, according to sources cited in discussions surrounding the new bill.

What was once a less common method has now become the primary approach, altering the landscape of the abortion debate and heightening frustrations among pro-life advocates. They argue that federal action has been lacking in response to this significant change.

What once represented a smaller share of procedures has quietly become the dominant method, reshaping the abortion debate and fueling growing frustration among pro-life advocates who argue Washington has been slow to respond to the shift.

For them, the fight after Roe did not end. It simply moved.

Instead of centering on clinics and procedures, the debate has increasingly turned to pills prescribed through telehealth consultations and delivered through the mail.

Hawley argues that shift has created a direct conflict between federal drug policy and state abortion laws enacted after Roe was overturned.

“We’ve known for years that mifepristone is risky but it’s really just in the last few years that we’ve learned that this drug is inherently dangerous and it is inherently prone to abuse,” Hawley said while discussing the legislation.

The Missouri senator also pointed to research he says shows complications tied to the drug may be far more common than federal regulators have acknowledged.

“What it means in practice is internal infections, sepsis, a trip to the emergency room, a life-threatening condition, in 11 percent of cases,” he said, referencing research examining hundreds of thousands of prescriptions.

Even so, the growing use of abortion pills has dramatically changed how abortions take place in the United States.

Where abortion once largely occurred in clinics under direct medical supervision, the process can now begin with an online consultation and end with pills arriving by mail. That shift has made the issue harder for states to regulate and placed renewed attention on the federal agencies responsible for approving and regulating the drugs themselves.

Hawley and other pro-life lawmakers argue the rise of telemedicine prescriptions and interstate delivery of abortion pills has opened the door to widespread misuse while weakening the ability of states to enforce their own abortion laws.

Why Aren’t American Feminists Celebrating Freedom of Iranian Women? Answer: Look at Their Priorities

The legislation faces an uncertain path in a closely divided Senate, but its introduction marks a significant shift in the abortion debate.

For decades, abortion policy in the United States revolved around regulating clinics, facilities, and surgical procedures. That framework assumed abortion was something performed inside a medical facility under the supervision of a physician. Medication abortion has upended that model, shifting the fight away from clinics and toward pills that can be prescribed through telemedicine and delivered through the mail.

Medication abortion now drives the majority of abortions in the United States.

Hawley’s bill goes straight after the drug itself